New Data Gives Adherium Fuel to Accelerate Digital Tech Adoption in Drug Sector - ResearchAndMarkets.com

DUBLIN--()--The "New Data Gives Adherium Fuel to Accelerate Digital Tech Adoption in Drug Sector" report has been added to ResearchAndMarkets.com's offering.

With nearly 40 published peer-reviewed journal articles under its belt, Adherium is hoping that the latest clinical data which underlines the ability of the company's Smartinhaler to improve outcomes for children with poorly controlled asthma should boost the pairing of digital technologies with drugs.

Adherium Ltd.'s Smartinhaler electronic monitoring tool - which incorporates reminder alarms and feedback - used with asthma medication delivery in children with poorly controlled asthma not only helps reduce the frequency of exacerbations, but also improves medication adherence significantly.

For more information about this report visit https://www.researchandmarkets.com/research/n2n9bg/new_data_gives?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals